GC
RCKT icon

Guggenheim Capital’s Rocket Pharmaceuticals RCKT Stock Holding History

Guggenheim Capital’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,985
Closed -$269K – 1929
2024
Q1 		$269K Buy
9,985
+1,605
+19% +$45.6K ﹤0.01% 1694
2023
Q4 		$251K Buy
+8,380
New +$185K ﹤0.01% 1736
2023
Q2 		– Sell
-11,757
Closed -$201K – 1927
2023
Q1 		$201K Buy
11,757
+1,087
+10% +$21.3K ﹤0.01% 1804
2022
Q4 		$209K Buy
+10,670
New +$196K ﹤0.01% 1793
2017
Q4 		– Sell
-2,610
Closed -$19K – 2792
2017
Q3 		$19K Buy
+2,610
New +$11.9K ﹤0.01% 2752

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return